The development of a novel immunoassay for the quantification of active tryptase Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020
Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021
Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD Source: Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019 Year: 2020
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
A new investigational use only automated immunoassay for periostin Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
An innovative high sensitivity tool for active neutrophil elastase quantification Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019
New enzyme linked immunosorbent assay using recombinant antigens from Saccharopolyspora rectivirgula for farmer‘s lung disease serodiagnosis Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Thrombin activatable fibrinolytic inhibitor in sera from NSCLC patients Source: Eur Respir J 2005; 26: Suppl. 49, 91s Year: 2005
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Rationale for active detection of COPD Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD Year: 2009
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019
Increased intraalveolar levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with interstitial lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 586s Year: 2002
Serological detection of elastin fragments in COPD and IPF patients Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012
Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 196s Year: 2001
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary Mycobacterium avium-intracellulare complex (MAC) disease Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007